146 related articles for article (PubMed ID: 35918489)
1. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019.
Azangou-Khyavy M; Saeedi Moghaddam S; Rezaei N; Esfahani Z; Rezaei N; Azadnajafabad S; Rashidi MM; Mohammadi E; ; Tavangar SM; Jamshidi H; Mokdad AH; Naghavi M; Farzadfar F; Larijani B
Sci Rep; 2022 Aug; 12(1):13231. PubMed ID: 35918489
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019.
Ajam A; Shobeiri P; Keykhaei M; Moghaddam SS; Momtazmanesh S; Masinaei M; Esfahani Z; Rezaei N; Naderian M; Aminorroaya A; Rashidi MM; Rezaei N; Larijani B; Malakan Rad E; Farzadfar F
Int J Cardiol; 2022 Sep; 363():202-209. PubMed ID: 35777487
[TBL] [Abstract][Full Text] [Related]
3. National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
Heidari-Foroozan M; Aryan A; Esfahani Z; Shahrbaf MA; Moghaddam SS; Keykhaei M; Ghasemi E; Rashidi MM; Rezaei N; Ghamari SH; Abbasi-Kangevari M; Fateh SM; Farzi Y; Rezaei N; Larijani B
Respir Res; 2023 Mar; 24(1):74. PubMed ID: 36906596
[TBL] [Abstract][Full Text] [Related]
4. The national trend of the gastric cancer burden in Iran from 1990 to 2017.
Fattahi N; Moghaddam SS; Rezaei N; Rezaei N; Fattahi E; Moradveisi B; Roshani S; Farzi Y; Zakaryaei F; Miraki A; Moradi-Lakeh M; Mokdad AH; Naghavi M; Farzadfar F
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e96-e102. PubMed ID: 33629817
[TBL] [Abstract][Full Text] [Related]
5. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
GBD 2015 Chronic Respiratory Disease Collaborators
Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
[TBL] [Abstract][Full Text] [Related]
6. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
7. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.
Bao WQ; Zi H; Yuan QQ; Li LY; Deng T
Thorac Cancer; 2021 Sep; 12(18):2494-2503. PubMed ID: 34355519
[TBL] [Abstract][Full Text] [Related]
8. Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
Sepanlou SG; Parsaeian M; Krohn KJ; Afshin A; Farzadfar F; Roshandel G; Karimkhani C; Bazargan-Hejazi S; Kiadaliri AA; Ahmadieh H; Djalalinia S; Ebrahimi H; Eshrati B; Esteghamati AR; Farvid MS; Fereshtehnejad SM; Hafezi-Nejad N; Hassanvand MS; Heydarpour P; Islami F; Karimi SM; Katibeh M; Khosravi A; Khubchandani J; Mahdavi M; Pishgar F; Qorbani M; Rahimi-Movaghar V; Safi S; Sahraian MA; Shahraz S; Sheikhbahaei S; Mohammadi A; Mokdad AH; Vos T; Murray CJL; Moradi-Lakeh M; Naghavi M; Malekzadeh R
Arch Iran Med; 2017 Jul; 20(7):403-418. PubMed ID: 28745902
[TBL] [Abstract][Full Text] [Related]
9. Global Burden of Thyroid Cancer From 1990 to 2017.
Deng Y; Li H; Wang M; Li N; Tian T; Wu Y; Xu P; Yang S; Zhai Z; Zhou L; Hao Q; Song D; Jin T; Lyu J; Dai Z
JAMA Netw Open; 2020 Jun; 3(6):e208759. PubMed ID: 32589231
[TBL] [Abstract][Full Text] [Related]
10. The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017.
Ouyang G; Liu Q; Wu Y; Liu Z; Lu W; Li S; Pan G; Chen X
Cancer; 2021 Jul; 127(13):2238-2250. PubMed ID: 33748947
[TBL] [Abstract][Full Text] [Related]
11. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
12. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019.
Nejadghaderi SA; Saeedi Moghaddam S; Keykhaei M; Shobeiri P; Rezaei N; Rezaei N; Naghavi M; Larijani B; Farzadfar F
Front Endocrinol (Lausanne); 2023; 14():1115833. PubMed ID: 36923218
[TBL] [Abstract][Full Text] [Related]
13. Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017.
Shahrezaee M; Keshtkari S; Moradi-Lakeh M; Abbasifard M; Alipour V; Amini S; Arabloo J; Arzani A; Bakhshaei M; Barzegar A; Bijani A; Dianatinasab M; Eskandarieh S; Gheshlagh RG; Ghashghaee A; Heidari-Soureshjani R; Irvani SSN; Lahimchi A; Maleki S; Manafi N; Manafi A; Mansournia MA; Mohammadian-Hafshejani A; Bandpei MAM; Moradzadeh R; Naderi M; Pakshir K; Rafiei A; Rashedi V; Rezaei N; Rezapour A; Sahraian MA; Shahabi S; Shamsi M; Soheili A; Soroush A; Zamani M; Mohajer B; Farzadfar F
Arch Osteoporos; 2020 Jul; 15(1):103. PubMed ID: 32651719
[TBL] [Abstract][Full Text] [Related]
14. National and subnational burden of brain and central nervous system cancers in Iran, 1990-2019: Results from the global burden of disease study 2019.
Mahdavi M; Moghaddam SS; Abbasi-Kangevari M; Mohammadi E; Shobeiri P; Sharifi G; Jafari A; Rezaei N; Ebrahimi N; Rezaei N; Ghamari SH; Malekpour MR; Khalili M; Larijani B; Kompani F
Cancer Med; 2023 Apr; 12(7):8614-8628. PubMed ID: 36622061
[TBL] [Abstract][Full Text] [Related]
15. Burden of multiple sclerosis in Iran from 1990 to 2017.
Fattahi N; Saeedi Moghaddam S; Mohebi F; Rezaei N; Masinaei M; Fateh SM; Soleymani Hassanlouei E; Manoochehri F; Fattahi E; Sahraian MA; Moradi-Lakeh M; Mokdad AH; Naghavi M; Farzadfar F
BMC Neurol; 2021 Oct; 21(1):400. PubMed ID: 34654397
[TBL] [Abstract][Full Text] [Related]
16. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.
Li N; Deng Y; Zhou L; Tian T; Yang S; Wu Y; Zheng Y; Zhai Z; Hao Q; Song D; Zhang D; Kang H; Dai Z
J Hematol Oncol; 2019 Dec; 12(1):140. PubMed ID: 31864424
[TBL] [Abstract][Full Text] [Related]
17. Trends in health burden of ambient particulate matter pollution in Iran, 1990-2010: findings from the Global Burden of Disease study 2010.
Poursafa P; Kelishadi R; Ghasemian A; Sharifi F; Djalalinia S; Khajavi A; Nejatifar M; Asayesh H; Mansourian M; Qorbani M; Ansari H
Environ Sci Pollut Res Int; 2015 Dec; 22(23):18645-53. PubMed ID: 26490896
[TBL] [Abstract][Full Text] [Related]
18. Attributable disease burden related to low bone mineral density in Iran from 1990 to 2019: results from the Global Burden of Disease 2019.
Azangou-Khyavy M; Saeedi Moghaddam S; Mohammadi E; Shobeiri P; Rashidi MM; Ahmadi N; Shahsavan S; Shirzad Moghaddam Z; Sohrabi H; Pourghasem F; Kalantar R; Ghaffari A; Hashemi SM; Rezaei N; Larijani B
Arch Osteoporos; 2022 Nov; 17(1):140. PubMed ID: 36355233
[TBL] [Abstract][Full Text] [Related]
19. The burden of osteoarthritis due to high Body Mass Index in Iran from 1990 to 2019.
Darbandi M; Shadmani FK; Miryan M; Ghalandari M; Mohebi M; Jam SA; Pasdar Y
Sci Rep; 2023 Jul; 13(1):11710. PubMed ID: 37474588
[TBL] [Abstract][Full Text] [Related]
20. The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019.
Pan H; Zhao Z; Deng Y; Zheng Z; Huang Y; Huang S; Chi P
BMC Public Health; 2022 Oct; 22(1):1896. PubMed ID: 36221047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
